SpendRule Launches AI Contract Intelligence to Curb $32 Billion in Healthcare Overpayments

New updates have been reported about SpendRule.

SpendRule has introduced an AI-driven contract intelligence platform that validates healthcare purchased-services invoices against contract terms before payment, positioning the company at the center of a $323 billion spend category long plagued by limited control and visibility. By embedding real-time contract enforcement into existing accounts payable workflows, SpendRule aims to convert a historically reactive audit function into proactive prevention, directly targeting an estimated $32 billion in annual preventable overpayments.

The platform is already in production at several health systems, including OSF HealthCare, Kettering Health, MemorialCare and MUSC Health, indicating early commercial traction and proof of concept. SpendRule’s system encodes complex, often lengthy purchased-services contracts into executable logic, enabling automated four-way matching of purchase orders, receipts, invoices and contract terms, flagging discrepancies with evidence upstream without requiring changes to incumbent ERP or AP systems.

For health systems, purchased services typically account for nearly half of non-labor spend, yet most invoices are approved without detailed validation due to contract complexity and resource constraints, leading to overpayments and weak vendor performance oversight. Executives at OSF HealthCare report that SpendRule now performs invoice-to-contract validation automatically across thousands of contracts, which is expected to reduce payment leakage and free internal teams from thousands of hours of manual review annually.

CTO and co-founder Joseph Akintolayo frames SpendRule’s core innovation as turning dormant contract documents into active code, while CEO and co-founder Chris Heckler emphasizes that the platform is designed to ensure identified savings actually materialize on the income statement. Backed by investors including Abundant Venture Partners, MemorialCare Innovation Fund and Zeal Capital Partners, and supported by commercial acceleration through the Abundant Alliance, SpendRule is positioned to scale its footprint as health systems look for AI-enabled tools to tighten spend governance, improve margin resilience and institutionalize contract compliance in a structurally pressured reimbursement environment.